Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

BD Contact Information: BD Global Product Incident Report (Pir) Form 1501-092-011-R

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

BD GLOBAL PRODUCT INCIDENT REPORT (PIR) FORM

1501-092-011-R

1. BD Contact Information
Email
Employee Name
(For Internal Use Only)
Phone

2. Customer Information
Reporter Name/Title

Facility name

Address

City/Region/State/Post Code/ Country

Country Event Occurred

Phone/Email

Report received by
Phone Email Other Specify:
(For Internal Use Only)

3. Product Details
Product name

Lot number(s) and/or Serial number(s)

Material/Catalog Number

Quantity Involved Contaminated? Yes No

Used product available to be returned for evaluation No Yes How many units?

Unused devices from the same lot number available


N/A No Yes How many units?
for evaluation (representative samples)

Other location
Current location of device(s) End user Distributor Destroyed
Specify:

Replacement 4. Incident Date (DD/


Replacement or MM/YYYY)
Credits for affected
devices? 5. BD Awareness Date (DD/
(For Internal Use Only) Credit MM/YYYY)
(For Internal Use Only)

Once completed, this document is considered a record that must be stored in


accordance with company procedures.
This document contains confidential, proprietary information of BD or one of its subsidiaries. It may not be copied or reproduced without Page
prior written permission from BD. 1 of 2
BD GLOBAL PRODUCT INCIDENT REPORT (PIR) FORM
1501-092-011-R

6. Description
INFORMATION: Give specific and objective details of feedback or event. Include copies of all relevant correspondence, photographs etc.
Where/When does the problem occur? Physical location of defect on the device, Step in the Process/Procedure, What Happened vs Expected? Was there any
patient/end user involvement? Was the intent of the process/procedure changed?)
I.e. The needle was clogged and the user was unable to administer insulin. However, the patient was able to administer the insulin with a second needle.

How often has the defect occurred? Once Several times How many times? Whole batch

7. Adverse Event Questions


When did the incident occur? Before Use During Use After Use Unknown

No Yes Date: Time:

Death? Detailed Death Description:

Unknown

Serious Injury Unknown No Yes Description:

Erroneous Results Unknown No Yes Description:

Course of treatment changed due to event


Include any alternate testing provided relative to Unknown No Yes Description:
the change in treatment

Exposure to Blood/Bodily Fluid


Include exposure of toxic medication to skin and Unknown No Yes Description:
list the specific medication that leaked. Indicate if
exposure to mucosal membrane occurred

Medical int. other than first aid


X‐ray, CT Scan, MRI, Ultrasound, delay or change
Unknown No Yes Description:
in treatment/diagnosis, administration of
antibiotics, surgical removal of a cannula, and etc.

Needle/Probe Stick Unknown No Yes Description:

Safety Issue
Retraction failures, shielding failures, safety Unknown No Yes Description:
feature failed to cover the needle properly.
Indicate whether the feature failed prior to use

Other actions taken


Test or admin of medication (drugs/solutions) due
to over or under dosage, imaging studies, admin of Description:
Unknown No Yes
prophylactic/antibiotics, blood transfusion ,admin
of antivirals due to needle stick, post lab testing,
hospitalization

Once completed, this document is considered a record that must be stored in


accordance with company procedures.
This document contains confidential, proprietary information of BD or one of its subsidiaries. It may not be copied or reproduced without Page
prior written permission from BD. 2 of 2

You might also like